Launch week offerEnds in00h00m00s

annual Promonthly Pro

Heather Gray-Edwards

Has grant

University of Massachusetts Chan Medical School

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Neuropsychology Neuropsychology professors in United States

Recent Grants

Grant: Open

AAV Gene Therapy for Sialidosis: from Mice to IND

Open Date: 2024-08-01

Close Date: 2029-05-31

Grant: Close

Generation of a Large Animal Model of Sialidosis to Enable Future Translation of Novel Therapeutics

Open Date: 2023-01-01

Close Date: 2024-12-31

Grant: Close

Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes

Open Date: 2020-09-01

Close Date: 2025-05-31

Grant: Close

Global AAV gene therapy of Tay-Sachs disease in sheep.

Open Date: 2016-12-01

Close Date: 2022-02-28

Grant: Close

In vivo magnetic resonance-based analysis of inherited neurologic disease after g

Open Date: 2013-04-01

Close Date: 2016-03-31

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

ITALY

View details

Christiano Alves

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Miguel Sena-Esteves

Associate Professor

University of Massachusetts Chan Medical School

UNITED STATES

View details

Maninder Sandey

Anatomic Pathologist/Assistant Professor

Auburn University

UNITED STATES

View details

Richard Wynn

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Heather Gray-Edwards

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (13)

Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy

Intravenous gene therapy improves lifespan and clinical outcomes in a feline model of Sandhoff disease

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial

Intracerebroventricular<i> SPAST</i>-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of<i> SPG4</i> hereditary spastic paraplegia

Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease.

Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/- mice.

An siRNA targeting <i>S6k1</i> identifies photoreceptor phospholipid metabolism as a contributor to lipid buildup in age-related macular degeneration.

Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice

BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease

Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Five-year analysis of efficacy and safety ofa bidirectional AAV gene therapy in Tay-Sachs sheep

Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases

Collaborators (13)

Dan Wang

Eva-Maria Ratai

Terence Flotte

Allison Keeler-Klunk

Jun Xie

Luke Chao

Rachael Gately

Srinivasan Jayakumar

Giacomo Parigi

Christiano Alves

Miguel Sena-Esteves

Maninder Sandey

Richard Wynn

Make your next move.

Heather Gray-Edwards

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (13)

Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy

Intravenous gene therapy improves lifespan and clinical outcomes in a feline model of Sandhoff disease

AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial

Intracerebroventricular<i> SPAST</i>-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of<i> SPG4</i> hereditary spastic paraplegia

Cerebrospinal delivery of a bidirectional AAV9 vector improves optic nerve and retinal pathology in a sheep model of Tay-Sachs disease.

Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/- mice.

An siRNA targeting &lt;i&gt;S6k1&lt;/i&gt; identifies photoreceptor phospholipid metabolism as a contributor to lipid buildup in age-related macular degeneration.

Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice

BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease

Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Five-year analysis of efficacy and safety ofa bidirectional AAV gene therapy in Tay-Sachs sheep

Neuroimaging Applications for the Delivery and Monitoring of Gene Therapy for Central Nervous System Diseases

Collaborators (13)

Dan Wang

Eva-Maria Ratai

Terence Flotte

Allison Keeler-Klunk

Jun Xie

Luke Chao

Rachael Gately

Srinivasan Jayakumar

Giacomo Parigi

Christiano Alves

Miguel Sena-Esteves

Maninder Sandey

Richard Wynn

Make your next move.

An siRNA targeting <i>S6k1</i> identifies photoreceptor phospholipid metabolism as a contributor to lipid buildup in age-related macular degeneration.